Biomedicines (Nov 2023)

Alveolar Type 2 Epithelial Cell Organoids: Focus on Culture Methods

  • Krishan Gopal Jain,
  • Nan Miles Xi,
  • Runzhen Zhao,
  • Waqas Ahmad,
  • Gibran Ali,
  • Hong-Long Ji

DOI
https://doi.org/10.3390/biomedicines11113034
Journal volume & issue
Vol. 11, no. 11
p. 3034

Abstract

Read online

Lung diseases rank third in terms of mortality and represent a significant economic burden globally. Scientists have been conducting research to better understand respiratory diseases and find treatments for them. An ideal in vitro model must mimic the in vivo organ structure, physiology, and pathology. Organoids are self-organizing, three-dimensional (3D) structures originating from adult stem cells, embryonic lung bud progenitors, embryonic stem cells (ESCs), and induced pluripotent stem cells (iPSCs). These 3D organoid cultures may provide a platform for exploring tissue development, the regulatory mechanisms related to the repair of lung epithelia, pathophysiological and immunomodulatory responses to different respiratory conditions, and screening compounds for new drugs. To create 3D lung organoids in vitro, both co-culture and feeder-free methods have been used. However, there exists substantial heterogeneity in the organoid culture methods, including the sources of AT2 cells, media composition, and feeder cell origins. This article highlights the currently available methods for growing AT2 organoids and prospective improvements to improve the available culture techniques/conditions. Further, we discuss various applications, particularly those aimed at modeling human distal lung diseases and cell therapy.

Keywords